Article Text

Download PDFPDF
CASE REPORT
Delayed recurrent pleuropericardial effusions following atrial septal defect closure with Amplatzer septal occluder device: a case of postpericardiotomy syndrome?
  1. Grace Kwok1,
  2. Rachel Witts2,
  3. Alessandra Frigiola3
  1. 1Department of Cardiology, Guy’s and St Thomas’ Hospital, London, UK
  2. 2Guy’s and St Thomas’ Hospital, London, UK
  3. 3Adult Congenital Heart Disease, Guy’s and St Thomas’ Hospital, London, UK
  1. Correspondence to Dr Grace Kwok, grace.kwok{at}doctors.org.uk

Summary

The authors present the case of a 41-year-old woman, who presented with moderate pericardial effusion and bilateral pleural effusion 11 months following a secundum atrial septal defect closure with an Amplatzer septal occluder (ASO) device. The acute presentation responded well to diuretics and a short course of corticosteroid therapy. The patient, however, continued to experience pleuritic chest pain and a recurrence of pericardial effusion a month later. The patient showed significant symptomatic improvement with a 2-month course of down-titrating prednisolone. Six months later, the echocardiogram showed complete remission of pleural and pericardial effusion. The possibility of cardiac erosion following ASO implantation has been excluded. The aetiology of the reoccurrence of steroid-responsive pleuropericarditis remains unknown.

  • cardiovascular medicine
  • interventional cardiology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors AF identified the case as a suitable case for submission and offered guidance throughout. RW collected the information required for the case and contributed to the write-up. GK completed the write-up, discussion and sought consent from the patient.

  • Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.